Live Breaking News & Updates on Igraine treatment

Stay updated with breaking news from Igraine treatment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Selenium supplements may offer migraine support: RCT

Daily supplementation with selenium may reduce the frequency and severity of headaches in people suffering from migraines, says a new study from Iran. ....

Isfahan , Esfahan , Iran , Iranian , Joyce-mccann , Bruce-ames , Isfahan-university-of-medical-sciences , Drug-administration , Metabolism-center , Hospital-oakland-research-institute , Isfahan-university , Medical-sciences

Benefits of EPA for migraine, vitamin D in reducing menstrual pain and more

This round-up looks at the latest health and nutrition research on the benefits of eicosapentaenoic acid (EPA) in reducing migraine frequency, the use of caffeine in enhancing sports performance among female athletes, vitamin D for reducing menstrual pain and more. ....

Taiwan , Researchers-at-deakin-university-australia , Deakin-university-australia , Research , Mega-3 , Omen-039s-health , Pa , Itamin-d , Affeine , Igraine , Menstrual-pain

Muscatine clinic now offers Botox injections to help treat severe migraines

Recently, the staff at the North Port Family Medicine Clinic in Muscatine have been able to offer a new Botox injection service to those suffering from frequent migraines. ....

Matt-mckinney , Broadlawns-medical-center , Unitypoint-clinic-north-port , North-port , Des-moines , Muscatine , Uscatine , Owa , Orth-port , Orth-port-family-medicine-clinic , Local-clinic , Otox

AXSOME ALERT: Bragar Eagel & Squire, P.C. is Investigating Axsome Therapeutics, Inc. on ...

NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Axsome Therapeutics, Inc. (NASDAQ: AXSM) ....

New-york , United-states , California , Marion-passmore , Brandon-walker , Bragar-eagel-squire , Drug-administration , Nasdaq , Exchange-commission , Axsome-therapeutics-inc , Axsome-therapeutics , Class-period